DCM
CVS icon

Deuterium Capital Management’s CVS Health CVS Stock Holding History

Deuterium Capital Management’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-2,807
Closed -$262K – 95
2022
Q4 		$262K Buy
+2,807
New +$271K 0.69% 42
2022
Q3 		– Sell
-2,740
Closed -$254K – 40
2022
Q2 		$254K Hold
2,740
– – 0.86% 27
2022
Q1 		$277K Buy
+2,740
New +$288K 0.36% 48

Other funds holding CVS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

Deuterium Capital Management's CVS Position: Q1 2023 in Review

Deuterium Capital Management sold out of CVS Health (CVS) in Q1 2023, closing a stake of 2,807 shares — an estimated $262K sold.

Deuterium Capital Management first reported a position in CVS in Q1 2022 and held it in 3 quarters. The position peaked at $277K in Q1 2022. 2,267 funds tracked by Wall St. Rank hold CVS as of Q1 2023.

  • Deuterium Capital Management reported no remaining CVS Health position as of Q1 2023 after selling out during the quarter.
  • Deuterium Capital Management sold 2,807 CVS Health shares in Q1 2023, an estimated $262K.
  • Deuterium Capital Management first reported a position in CVS Health in Q1 2022 and held it in 3 quarters.
  • Deuterium Capital Management's CVS Health position peaked at $277K in Q1 2022.
  • 2,267 funds tracked by Wall St. Rank held CVS Health as of Q1 2023.

Based on Deuterium Capital Management's 13F filing for Q1 2023, filed 12 May 2023.